Literature DB >> 26970354

Associations of low grade inflammation and endothelial dysfunction with depression - The Maastricht Study.

Fleur E P van Dooren1, Miranda T Schram2, Casper G Schalkwijk2, Coen D A Stehouwer2, Ronald M A Henry2, Pieter C Dagnelie3, Nicolaas C Schaper4, Carla J H van der Kallen2, Annemarie Koster5, Simone J S Sep2, Johan Denollet6, Frans R J Verhey7, Frans Pouwer6.   

Abstract

BACKGROUND: The pathogenesis of depression may involve low-grade inflammation and endothelial dysfunction. We aimed to evaluate the independent associations of inflammation and endothelial dysfunction with depressive symptoms and depressive disorder, and the role of lifestyle factors in this association.
METHODS: In The Maastricht Study, a population-based cohort study (n=852, 55% men, m=59.8±8.5years), depressive symptoms were assessed with the Patient Health Questionnaire-9 and (major and minor) depressive disorder with the Mini-International Neuropsychiatric Interview. Plasma biomarkers of inflammation (hsCRP, SAA, sICAM-1, IL-6, IL-8, TNF-α) and endothelial dysfunction (sVCAM-1, sICAM-1, sE-selectin, vWF) were measured with sandwich immunoassays and combined into two standardized sum scores.
RESULTS: Biomarkers of inflammation (hsCRP, TNF-α, SAA, sICAM-1) and endothelial dysfunction (sICAM-1, sE-Selectin) were univariately associated with depressive symptoms and depressive disorder. The sum scores of inflammation and endothelial dysfunction were associated with depressive disorder after adjustment for age, sex, type 2 diabetes, kidney function and prior cardiovascular disease (OR 1.54, p=0.001 and 1.40, p=0.006). Both sum scores remained significantly associated with depressive disorder after additional adjustment for lifestyle factors smoking, alcohol consumption and body mass index. The sum score of inflammation was also independently associated with depressive symptoms, while the sum score of endothelial dysfunction was not.
CONCLUSIONS: Inflammation and endothelial dysfunction are both associated with depressive disorder, independent of lifestyle factors. Our results might suggest that inflammation and endothelial dysfunction are involved in depression.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Depression; Endothelial dysfunction; Inflammation; Lifestyle factors

Mesh:

Substances:

Year:  2016        PMID: 26970354     DOI: 10.1016/j.bbi.2016.03.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  37 in total

Review 1.  Investigational drugs in recent clinical trials for treatment-resistant depression.

Authors:  Ricardo P Garay; Carlos A Zarate; Thomas Charpeaud; Leslie Citrome; Christoph U Correll; Ahcène Hameg; Pierre-Michel Llorca
Journal:  Expert Rev Neurother       Date:  2017-01-29       Impact factor: 4.618

Review 2.  Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors:  Christian Herder; Norbert Hermanns
Journal:  Semin Immunopathol       Date:  2019-02-18       Impact factor: 9.623

Review 3.  Inflammatory markers and depression in Parkinson's disease: a systematic review.

Authors:  Luis Guilherme Ramanzini; Luís Fernando Muniz Camargo; Juliana Oliveira Freitas Silveira; Guilherme Vargas Bochi
Journal:  Neurol Sci       Date:  2022-08-30       Impact factor: 3.830

Review 4.  The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders.

Authors:  Nathan M D'Cunha; Domenico Sergi; Melissa M Lane; Nenad Naumovski; Elizabeth Gamage; Anushri Rajendran; Matina Kouvari; Sarah Gauci; Thusharika Dissanayka; Wolfgang Marx; Nikolaj Travica
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

Review 5.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

6.  The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.

Authors:  Shipra Arya; Sujin Lee; Greg J Zahner; Beth E Cohen; Jade Hiramoto; Owen M Wolkowitz; Anjali Khakharia; Zachary O Binney; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2018-03-24       Impact factor: 4.268

7.  Genome-wide scan of depressive symptomatology in two representative cohorts in the United States and the United Kingdom.

Authors:  Krisztina Mekli; Drystan F Phillips; Thalida E Arpawong; Bram Vanhoutte; Gindo Tampubolon; James Y Nazroo; Jinkook Lee; Carol A Prescott; Adam Stevens; Neil Pendleton
Journal:  J Psychiatr Res       Date:  2018-02-10       Impact factor: 4.791

8.  Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuck; Gustavo C Ferreira; João Quevedo; João Seda Neto; Tatiana Amorim; Jose S Camelo; Ana Vitoria Barban Margutti; Rafael Hencke Tresbach; Fernanda Sperb-Ludwig; Raquel Boy; Paula F V de Medeiros; Ida Vanessa D Schwartz; Emilio Luiz Streck
Journal:  J Inherit Metab Dis       Date:  2018-05-08       Impact factor: 4.982

9.  Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function.

Authors:  Zhuxian Zhang; Panpan He; Mengyi Liu; Chun Zhou; Chengzhang Liu; Huan Li; Yuanyuan Zhang; Qinqin Li; Ziliang Ye; Qimeng Wu; Guobao Wang; Min Liang; Xianhui Qin
Journal:  Clin J Am Soc Nephrol       Date:  2021-05-29       Impact factor: 10.614

10.  Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder.

Authors:  Jingjing Zhou; Jia Zhou; Zuoli Sun; Lei Feng; Xuequan Zhu; Jian Yang; Gang Wang
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.